Mechanisms of cryoablation: clinical consequences on malignant tumors.
Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM.
Cryobiology. 2014 Feb;68(1):1-11. doi: 10.1016/j.cryobiol.2013.11.001. Epub 2013 Nov 13.
Nano-cryosurgery: advances and challenges.
Liu J, Deng ZS.
J Nanosci Nanotechnol. 2009 Aug;9(8):4521-42. doi: 10.1166/jnn.2009.1264.
Cryosurgery of malignant and premalignant diseases of the skin: a simple approach.
Sinclair RD, Dawber RP.
Australas J Dermatol. 1995 Aug;36(3):133-42. doi: 10.1111/j.1440-0960.1995.tb00955.x.
Issues critical to the successful application of cryosurgical ablation of the prostate.
Baust JG, Gage AA, Klossner D, Clarke D, Miller R, Cohen J, Katz A, Polascik T, Clarke H, Baust JM.
Technol Cancer Res Treat. 2007 Apr;6(2):97-109. doi: 10.1177/153303460700600206.
Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy.
Bilchik AJ, Sarantou T, Foshag LJ, Giuliano AE, Ramming KP.
Surgery. 1997 Dec;122(6):1040-7; discussion 1047-8. doi: 10.1016/s0039-6060(97)90207-5.
Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
Kang SH, Kim JW, Bae JH, Park HS, Moon DG, Yoon DK, Cheon J, Kim JJ.
Asian J Androl. 2006 Sep;8(5):629-36. doi: 10.1111/j.1745-7262.2006.00176.x.
Progressing prostate carcinoma.
Haut MJ, Harryhill JF, Rosenstock J, Warhol MJ, Vitti R.
Oncologist. 2001;6(2):183-96. doi: 10.1634/theoncologist.6-2-183.
Cryotherapy.
Loening SA, Bonney WW, Fallon B, Gerber WL, Hawtrey CE, Lubaroff DM, Narayana AS, Culp DA.
Prostate. 1984;5(2):199-204. doi: 10.1002/pros.2990050209.
Cryosurgery in the treatment of oro-facial lesions.
Bansal A, Jain S, Gupta S.
Indian J Dent Res. 2012 Mar-Apr;23(2):297. doi: 10.4103/0970-9290.100468.
Cryosurgery in the treatment of cancer.
Gage AA.
Surg Gynecol Obstet. 1992 Jan;174(1):73-92.
